Furthermore evidence of OXPHOS dysfunction and defective ATP production in OPA1 animal models [19], [20], [21], [22], [23], [24] and skeletal muscle from ADOA patients is accumulating [18], [25], [26]. This evidence concerns the gene OPA1 and autosomal dominant optic atrophy.